topotecan
Selected indexed studies
- Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer. (J Clin Oncol, 1999) [PMID:10080612]
- Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer. (J Clin Oncol, 2006) [PMID:17135646]
- Topotecan in cervical cancer. (Int J Gynecol Cancer, 2007) [PMID:17997795]
_Worker-drafted node — pending editorial review._
Connections
topotecan is a side effect of
Sources
- Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer. (1999) pubmed
- Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer. (2006) pubmed
- Topotecan in cervical cancer. (2007) pubmed
- Topotecan for ovarian cancer. (2008) pubmed
- Topotecan in combination chemotherapy. (1997) pubmed
- Topotecan. A review of its potential in advanced ovarian cancer. (1998) pubmed
- Topotecan for the treatment of recurrent and stage IVB carcinoma of the cervix. (2010) pubmed
- Topotecan: a review of its efficacy in small cell lung cancer. (1999) pubmed
- Topotecan Liposomes: A Visit from a Molecular to a Therapeutic Platform. (2016) pubmed
- Topotecan - A novel topoisomerase I inhibitor: pharmacology and clinical experience. (1999) pubmed